These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 26126823)

  • 21. Allosteric Modulation of Class A GPCRs: Targets, Agents, and Emerging Concepts.
    Wold EA; Chen J; Cunningham KA; Zhou J
    J Med Chem; 2019 Jan; 62(1):88-127. PubMed ID: 30106578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biased Allosteric Modulators: New Frontiers in GPCR Drug Discovery.
    Slosky LM; Caron MG; Barak LS
    Trends Pharmacol Sci; 2021 Apr; 42(4):283-299. PubMed ID: 33581873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bitopic Ligands and Metastable Binding Sites: Opportunities for G Protein-Coupled Receptor (GPCR) Medicinal Chemistry.
    Fronik P; Gaiser BI; Sejer Pedersen D
    J Med Chem; 2017 May; 60(10):4126-4134. PubMed ID: 28140580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emerging paradigms in GPCR allostery: implications for drug discovery.
    Wootten D; Christopoulos A; Sexton PM
    Nat Rev Drug Discov; 2013 Aug; 12(8):630-44. PubMed ID: 23903222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. G-protein coupled receptors: advances in simulation and drug discovery.
    Miao Y; McCammon JA
    Curr Opin Struct Biol; 2016 Dec; 41():83-89. PubMed ID: 27344006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. G protein-coupled receptor transmembrane binding pockets and their applications in GPCR research and drug discovery: a survey.
    Kratochwil NA; Gatti-McArthur S; Hoener MC; Lindemann L; Christ AD; Green LG; Guba W; Martin RE; Malherbe P; Porter RH; Slack JP; Winnig M; Dehmlow H; Grether U; Hertel C; Narquizian R; Panousis CG; Kolczewski S; Steward L
    Curr Top Med Chem; 2011; 11(15):1902-24. PubMed ID: 21470172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The identification of high-affinity G protein-coupled receptor ligands from large combinatorial libraries using multicolor quantum dot-labeled cell-based screening.
    Fu J; Lee T; Qi X
    Future Med Chem; 2014 May; 6(7):809-23. PubMed ID: 24941874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative and systems pharmacology 2. In silico polypharmacology of G protein-coupled receptor ligands via network-based approaches.
    Wu Z; Lu W; Yu W; Wang T; Li W; Liu G; Zhang H; Pang X; Huang J; Liu M; Cheng F; Tang Y
    Pharmacol Res; 2018 Mar; 129():400-413. PubMed ID: 29133212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The therapeutic potential of allosteric ligands for free fatty acid sensitive GPCRs.
    Hudson BD; Ulven T; Milligan G
    Curr Top Med Chem; 2013; 13(1):14-25. PubMed ID: 23409763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allosteric modulators of G-protein-coupled receptors.
    May LT; Christopoulos A
    Curr Opin Pharmacol; 2003 Oct; 3(5):551-6. PubMed ID: 14559102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Pharmacochaperone-Based High-Throughput Screening Assay for the Discovery of Chemical Probes of Orphan Receptors.
    Morfa CJ; Bassoni D; Szabo A; McAnally D; Sharir H; Hood BL; Vasile S; Wehrman T; Lamerdin J; Smith LH
    Assay Drug Dev Technol; 2018 Oct; 16(7):384-396. PubMed ID: 30251873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current Trends in GPCR Allostery.
    Singh KD; Karnik SS
    J Membr Biol; 2021 Jun; 254(3):293-300. PubMed ID: 33471142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Quantitative Characterization of Functional Allosteric Effects.
    Kenakin T
    Curr Protoc Pharmacol; 2017 Mar; 76():9.22.1-9.22.10. PubMed ID: 28306151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beyond the Ligand: Extracellular and Transcellular G Protein-Coupled Receptor Complexes in Physiology and Pharmacology.
    Dunn HA; Orlandi C; Martemyanov KA
    Pharmacol Rev; 2019 Oct; 71(4):503-519. PubMed ID: 31515243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allosteric targeting of receptor tyrosine kinases.
    De Smet F; Christopoulos A; Carmeliet P
    Nat Biotechnol; 2014 Nov; 32(11):1113-20. PubMed ID: 25380447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synoptic pharmacology: Detecting and assessing the pharmacological significance of ligands for orphan receptors.
    Kenakin TP
    Pharmacol Res; 2016 Dec; 114():284-290. PubMed ID: 26804250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of GPCR Ligands by Molecular Docking Screening: Novel Opportunities Provided by Crystal Structures.
    Rodríguez D; Ranganathan A; Carlsson J
    Curr Top Med Chem; 2015; 15(24):2484-503. PubMed ID: 26126906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders.
    Conn PJ; Christopoulos A; Lindsley CW
    Nat Rev Drug Discov; 2009 Jan; 8(1):41-54. PubMed ID: 19116626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Orthosteric/allosteric bitopic ligands: going hybrid at GPCRs.
    Valant C; Sexton PM; Christopoulos A
    Mol Interv; 2009 Jun; 9(3):125-35. PubMed ID: 19592673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The 7 TM G-protein-coupled receptor target family.
    Jacoby E; Bouhelal R; Gerspacher M; Seuwen K
    ChemMedChem; 2006 Aug; 1(8):761-82. PubMed ID: 16902930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.